Clinical Gene Networks AB

Clinical Gene Networks AB is a company in Stockholm, Sweden that has taken part in 2 EU-funded projects since 2009, receiving €467k in EU funding.

EU funding received€467k
EU projects2
As coordinator0
Running now0
First EU project2009
Latest project2013
CountrySweden
EU registration (PIC)997830174
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Clinical Gene Networks AB's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€467k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • CVGENES-AT-TARGETPartner

    Exploitation of genomic variants affecting coronary artery disease and stroke risk for therapeutic intervention

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €398ktheir share
  • DOPAMINETPartner

    Molecular Networks of Dopaminergic Neurons in Chordates

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €69ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • arteriosclerosis
  • dementia
  • laser physics
  • lipids
  • microscopy
  • parkinson
  • proteins
  • stroke

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime